MEDICAL COSTS AVOIDED FOR PREVENTION OF STROKE WITH USE OF NOACS: ESTIMATES FOR THE REAL-WORLD

被引：0
|
作者：
Amin, Alpesh
Stokes, Michael
Makenbaeva, Dinara
Wiederkehr, Daniel
Gatt, Elyse
Wu, Ning
Lawrence, John
机构：
[1] Bristol Myers Squibb, Plainsboro, NJ USA
[2] Pfizer, New York, NY USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2014年 / 63卷 / 12期
关键词：
D O I：
10.1016/S0735-1097(14)60330-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1109-120
引用
收藏
页码：A330 / A330
页数：1
相关论文
共 50 条
  • [1] Real-world cost-effectiveness analysis of NOACs versus VKA for stroke prevention in Spain
    Escobar Cervantes, Carlos
    Marti-Almor, Julio
    Perez Cabeza, Alejandro Isidoro
    Bowrin, Kevin
    Llorac Moix, Aleix
    Genis Girones, Mar
    Gasche, David
    Millier, Aurelie
    Tardu, Jean
    Toumi, Mondher
    Briere, Jean-Baptiste
    PLOS ONE, 2022, 17 (04):
  • [2] Real-world costs of ischemic stroke by discharge status
    Mu, F.
    Hurley, D.
    Betts, K. A.
    Messali, A. J.
    Paschoalin, M.
    Kelley, C.
    Wu, E. Q.
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (02) : 371 - 378
  • [3] REAL-WORLD COSTS OF ISCHEMIC STROKE BY DISCHARGE STATUS
    Mu, F.
    Hurley, D.
    Betts, K.
    Messali, A.
    Paschoalin, M.
    Wu, E. Q.
    VALUE IN HEALTH, 2016, 19 (03) : A46 - A46
  • [4] MEDICAL RESOURCE USE AND COSTS OF SECONDARY HYPERPARTHYRODISM IN DIALYSIS PATIENTS IN THE REAL-WORLD SETTING
    Roggeri, Daniela Paola
    Conte, Ferruccio
    Rossi, Carlotta
    Cozzolino, Mario
    Zocchetti, Carlo
    Roggeri, Alessandro
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [5] Stroke Prevention in Atrial Fibrillation What Is Real World, and What Do Real-World Data Reveal?
    Healey, Jeff S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (02) : 154 - 155
  • [6] Real-World Use of Apixaban for Stroke Prevention in Atrial Fibrillation A Systematic Review and Meta-Analysis
    Proietti, Marco
    Romanazzi, Imma
    Romiti, Giulio Francesco
    Farcomeni, Alessio
    Lip, Gregory Y. H.
    STROKE, 2018, 49 (01) : 98 - +
  • [7] An assessment of the use of adhesion prevention therapy in a real-world setting
    Broder, M. S.
    Ory, C.
    Chang, E.
    Kemner, J.
    FERTILITY AND STERILITY, 2007, 88 : S255 - S255
  • [8] A real-world example of opportunity costs
    Engle, Carole R.
    AQUACULTURE ECONOMICS & MANAGEMENT, 2019, 23 (02) : 133 - 134
  • [9] Real-world resource use and costs of haemophilia A-related bleeding
    Shrestha, A.
    Eldar-Lissai, A.
    Hou, N.
    Lakdawalla, D. N.
    Batt, K.
    HAEMOPHILIA, 2017, 23 (04) : E267 - E275
  • [10] A real-world observational study of somatostatin analogue use and costs in Canada
    Cheung, Winson Y.
    Feuilly, Marion
    Laforty, Callahan
    Liovas, Anna
    McKechnie, Heather
    Loree, Jonathan M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
12345